Cargando…
Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378490/ http://dx.doi.org/10.1016/S0992-5945(20)30141-0 |
| _version_ | 1783562431108218880 |
|---|---|
| author | Dalmat, Yann-Mickael |
| author_facet | Dalmat, Yann-Mickael |
| author_sort | Dalmat, Yann-Mickael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7378490 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73784902020-07-24 Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines Dalmat, Yann-Mickael Option/Bio Article Elsevier Masson SAS. 2020-06 2020-07-24 /pmc/articles/PMC7378490/ http://dx.doi.org/10.1016/S0992-5945(20)30141-0 Text en Copyright © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Dalmat, Yann-Mickael Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title | Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title_full | Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title_fullStr | Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title_full_unstemmed | Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title_short | Tocilizumab et Sars-CoV-2 : des arthrites au relargage de cytokines |
| title_sort | tocilizumab et sars-cov-2 : des arthrites au relargage de cytokines |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378490/ http://dx.doi.org/10.1016/S0992-5945(20)30141-0 |
| work_keys_str_mv | AT dalmatyannmickael tocilizumabetsarscov2desarthritesaurelargagedecytokines |